Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Stagg

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Oncoimmunology|June 22, 2012
The double-edge sword effect of anti-CD73 cancer therapyJohn Stagg
Stem Cell Reviews|May 22, 2008
Mesenchymal stem cells in cancerJohn Stagg
Therapeutic Advances in Medical Oncology|May 2, 2013
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospectsJohn Stagg, Bertrand Allard
Cancer Cell|August 17, 2010
Her 2 in 1Mark J Smyth, John Stagg
Annual Review of Pharmacology and Toxicology|September 13, 2024
Targeting G Protein-Coupled Receptors in Immuno-Oncological TherapiesJohn Stagg, J Silvio Gutkind
Drug News & Perspectives|May 24, 2007
NK cell-based cancer immunotherapyJohn Stagg, Mark J Smyth
Journal of Biomedicine & Biotechnology|November 6, 2012
CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growthBertrand Allard, Martin Turcotte, John Stagg
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
Methods to Evaluate the Antitumor Activity of Immune Checkpoint Inhibitors in Preclinical StudiesBertrand Allard, David Allard, John Stagg
Expert Opinion on Therapeutic Targets|May 7, 2014
Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancerBertrand Allard, Martin Turcotte, John Stagg
Breast Care (Basel, Switzerland)|August 2, 2013
Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?John Stagg, Fabrice Andre, Sherene Loi
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Oncoimmunology|June 22, 2012
The double-edge sword effect of anti-CD73 cancer therapyJohn Stagg
Stem Cell Reviews|May 22, 2008
Mesenchymal stem cells in cancerJohn Stagg
Therapeutic Advances in Medical Oncology|May 2, 2013
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospectsJohn Stagg, Bertrand Allard
Cancer Cell|August 17, 2010
Her 2 in 1Mark J Smyth, John Stagg
Annual Review of Pharmacology and Toxicology|September 13, 2024
Targeting G Protein-Coupled Receptors in Immuno-Oncological TherapiesJohn Stagg, J Silvio Gutkind
Drug News & Perspectives|May 24, 2007
NK cell-based cancer immunotherapyJohn Stagg, Mark J Smyth
Journal of Biomedicine & Biotechnology|November 6, 2012
CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growthBertrand Allard, Martin Turcotte, John Stagg
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
Methods to Evaluate the Antitumor Activity of Immune Checkpoint Inhibitors in Preclinical StudiesBertrand Allard, David Allard, John Stagg
Expert Opinion on Therapeutic Targets|May 7, 2014
Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancerBertrand Allard, Martin Turcotte, John Stagg
Breast Care (Basel, Switzerland)|August 2, 2013
Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?John Stagg, Fabrice Andre, Sherene Loi
Pageof 11